Malignant Glioma
📧 Sign up to get email alerts when something new happens for Malignant Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Rotating Frame Relaxation and Diffusion Weighted Imaging of Human Gliomas
A completed clinical trial evaluating rotating frame relaxation and diffusion-weighted imaging in patients with gliomas.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Cetuximab-IRDye 800CW in Detecting Tumors in Patients With Malignant Glioma Undergoing Surgery [Phase 1, Phase 2]
Phase 1/2 trial evaluating cetuximab-IRDye 800CW for intraoperative detection of tumors in malignant glioma patients undergoing surgery; stu…
-
CLINICAL_TRIALS trial_result · 2018-02-06Clinical Trial Update: Bevacizumab, Temozolomide and Hypofractionated Radiotherapy for Patients With Newly Diagnosed Malignant Glioma [Phase 2]
Phase 2 trial evaluating bevacizumab, temozolomide, and hypofractionated radiotherapy in newly diagnosed malignant glioma; study status comp…
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme [Phase 2]
Phase II study of rindopepimut (CDX-110) in glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma [Phase 2]
A Phase 2 trial evaluated thalidomide, celecoxib, and combination chemotherapy in patients with relapsed or refractory malignant glioma; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma [NA]
A terminated clinical trial evaluating stem cell radiotherapy with temozolomide for newly diagnosed high-grade glioma has posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma [NA]
This Clinical Trial Update reports that a trial of Bevacizumab in combination with radiation therapy for recurrent malignant glioma has comp…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating vaccination with dendritic cells loaded with peptides for recurrent malignant glioma; completed with res…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Dendritic Cell Vaccine With Imiquimod for Patients With Malignant Glioma [Phase 1]
Phase 1 trial evaluating a dendritic cell vaccine with Imiquimod in malignant glioma has been completed. The study investigates safety and p…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: The Roles of Tissue Factor in Malignant Gliomas
Update on the roles of tissue factor in malignant gliomas, including considerations of venous thromboembolism in brain-tumor patients, from …
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)
A post-marketing all-case observational study of Gliadel wafer (carmustine implant) in malignant glioma has completed, evaluating safety and…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma [Phase 1, Phase 2]
This update describes the completion of a Phase 1/2 study evaluating galunisertib (LY2157299) in combination with temozolomide-based radioch…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Image Guided Reirradiation of High-grade Glioma [Phase 1, Phase 2]
A phase 1/2 clinical trial of image-guided reirradiation for high-grade glioma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas [Phase 1]
Phase 1 trial evaluating fluorodopa (FDOPA) PET/MRI for pre-operative evaluation of gliomas; the study status is terminated.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: LBH589 and Bevacizumab in Patients With Recurrent High Grade Glioma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the combination of panobinostat (LBH589) and bevacizumab in patients with recurrent malignan…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma [Phase 1]
Phase 1 trial update reporting completion of a pediatric study of Myocet (liposomal doxorubicin) in children with relapsed or refractory non…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma [Phase 1]
A Phase 1 study evaluating lomustine for bevacizumab-naive recurrent malignant glioma has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas [Phase 2]
A Phase 2 randomized, placebo-controlled trial evaluated armodafinil (Nuvigil) for fatigue in patients with malignant gliomas; results have …
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Comparative 2-D Tumor Analysis in Familial Gliomas
A completed clinical trial report presents results from a comparative 2-D tumor analysis study in patients with familial gliomas.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Characterization of Serial Magnetic Resonance Spectroscopy Imaging in Patients With Malignant Glioma Undergoing Radiotherapy
A completed clinical trial update on the characterization of serial MR spectroscopy imaging in patients with malignant glioma undergoing rad…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Clinical Study on 5-aminolevulinic Acid Hydrochloride (5-ALA) for Fluorescence-guided Resection of Malignant Gliomas [Phase 1, Phase 2]
Clinical trial update on 5-ALA hydrochloride for fluorescence-guided resection of malignant gliomas (Phase 1/Phase 2), now completed.
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: AMG 595 First-in-Human in Recurrent Gliomas [Phase 1]
Amgen completed a first-in-human Phase 1 trial of AMG 595 in recurrent gliomas to assess safety and early signals of activity. The study inc…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma [Phase 2]
This Phase 2 clinical trial update reports results for temozolomide in patients with recurrent glioblastoma multiforme or other malignant gl…
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure [Phase 1]
A Phase 1/2 trial of CTO in combination with Bevacizumab for recurrent malignant glioma after Bevacizumab failure has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Early-Phase Safety of Proton Therapy Equipment [NA]
This early-phase safety study evaluated proton therapy equipment for treating several cancers and has completed enrollment, with results pos…